Eyedaptic is introducing an agentic artificial intelligence (AI) visual assistant designed for integration with its latest iteration of AI-embedded smart glasses.
Let’s start with Eyedaptic.
The privately held company makes AI-enabled, augmented reality (AR) smart glasses designed to enhance functional vision rather than slow disease progression.
How does it work?
Its proprietary Simulated Natural Vision Software uses real-time pixel manipulation to optimize a patient’s remaining peripheral vision, “simulating” clearer sight in a hands-free, glasses-style design (see the clinical research behind the tech).
The target patients: those diagnosed with age-related macular degeneration (AMD) and diabetic retinopathy (DR).
And how many iterations are there?
While earlier models (EYE2,3, and 4) included this patented technology, the company’s currently available glasses include: EYE5, EYE6, and, as of March 2026, the EYE7.
Among the shared features:
- Sub-3-oz frame
- Facial detection
- Auto-zoom for reading text
- Contrast enhancement controls
- 2-in-1 wearable and handheld magnifier
- EyeSwitch technology
To note: Each pair of glasses also accommodates prescriptions via adjustable prescription inserts that can be worn over a patient’s existing glasses.
Nice! And are these also FDA cleared?
Per Eyedaptic, the glasses are Class I, 510(k)-exempt medical devices—meaning they pose minimal risk and do not require premarket clearance or approval.
Now to this virtual assistant …
If you recall, we briefly mentioned this new addition back in March, during our coverage of the EYE7 launch.
Called Eva, the agentic AI visual assistant was available through an early access beta program for users to test its capabilities and offer feedback.
But now: It’s available for E7 wearers following a remote software upgrade as part of the new Eyedaptic Virtual Assistant Family platform.
- To note: This platform also features the EYE6’s virtual assistant, Ivy.
Tell me more.
Eva incorporates AI into Eyedaptics’ smart glasses to create an integrated experience that allows for:
- Interpretation of a user’s visual environment
- Inference of user intent through unstructured, “natural” language in real time
- Includes conversational skills in 99+ languages
- Active control of vision-enhancement features to support everyday activities and greater independence
Combined, these comprise what the company calls Eyegentic AI, a single system representing a “new category of assistive technology.”
See here for more capabilities.
So how would this work in real world practice?
Eyedaptic offered this example:
When a user says, “I can’t read that,” Eva interprets the request, infers meaning, and adjusts the visual experience—all without requiring a specific command.
Watch below for a demonstration.
https://vimeo.com/1237726030?fl=pl&fe=cm
And is there any clinical data supporting its use?
Per Eyedaptic, clinical testing resulted in Eva demonstrating >99% reading accuracy and 97% command accuracy.
- To note: The full data from this testing is not publicly available.
Also worth noting: Results recently presented from an independent clinical study found that the smart glasses delivered an average 5.7-line acuity gain among AMD patients.
- See here for more on those findings.
Last question: How can patients try out Eva—and these smart glasses?
Keep in mind: Eva is currently only available with the E7 smart glasses.
- Click here to request more information (including pricing) on the product.
- And for current Eyedaptic users looking to upgrade their glasses to the EYE7: